Literature DB >> 28116728

Isolation and Culture of Endothelial Cells from Large Vessels.

Augusto C Montezano1, Karla B Neves2, Rheure A M Lopes2, Francisco Rios2.   

Abstract

The endothelium, which is at the interface between circulating blood and the vascular wall, comprises a simple squamous layer of cells that lines the inner surface of all blood vessels. Endothelial cells are highly metabolically active and play an important role in many physiological functions, including control of vasomotor tone, blood cell trafficking, vascular permeability, and maintenance of vascular integrity (Mensah, Vascul Pharmacol 46(5):310-314, 2007; Yetik-Anacak and Catravas, Vascul Pharmacol 45(5):268-276, 2006). Endothelial cells are characteristically 'quiescent' in that they do not actively proliferate, with the average lifespan of an endothelial cell being >1 year. The endothelium is very sensitive to mechanical stimuli (stretch, shear stress, pressure), humoral agents (angiotensin II (Ang II), endothelin-1 (ET-1), aldosterone, bradykinin, thromoxane) and chemical factors (glucose, reactive oxygen species (ROS)) and responds by releasing endothelial-derived mediators, such as nitric oxide (NO), prostacyclin (PGI2), platelet-activating factor (PAF), C-type atrial natriuretic peptide (ANP), and ET-1 to regulate vascular tone, prevent thrombosis and inflammation, and maintain structural integrity. Primary culture of endothelial cells is an important tool in dissecting the role of the endothelium in many physiological or pathological responses. This chapter describes the explant method for culture of endothelial cells from large vessels. Cells derived by the protocol described here can be used for cell biology and molecular biology studies in hypertension and other cardiovascular diseases where endothelial function may be impaired.

Entities:  

Keywords:  Endothelial cells; Large vessels; Primary culture

Mesh:

Year:  2017        PMID: 28116728     DOI: 10.1007/978-1-4939-6625-7_26

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  6 in total

1.  Topography-induced large-scale antiparallel collective migration in vascular endothelium.

Authors:  Claire Leclech; David Gonzalez-Rodriguez; Aurélien Villedieu; Thévy Lok; Anne-Marie Déplanche; Abdul I Barakat
Journal:  Nat Commun       Date:  2022-05-19       Impact factor: 17.694

2.  Interferon activated gene 204 protects against bone loss in experimental periodontitis.

Authors:  Karen V Swanson; Mustafa Girnary; Tomaz Alves; Jenny Py Ting; Kimon Divaris; Jim Beck; Carolina Maschietto Pucinelli; Raquel Assed Bezerra da Silva; Dilek Uyan; Justin E Wilson; William T Seaman; Jennifer Webster-Cyriaque; Nishma Vias; Yizu Jiao; Lloyd Cantley; Arnaud Marlier; Roland R Arnold; Julie T Marchesan
Journal:  J Periodontol       Date:  2022-06-10       Impact factor: 4.494

3.  Bacteria-triggered tumor-specific thrombosis to enable potent photothermal immunotherapy of cancer.

Authors:  Xuan Yi; Hailin Zhou; Yu Chao; Saisai Xiong; Jing Zhong; Zhifang Chai; Kai Yang; Zhuang Liu
Journal:  Sci Adv       Date:  2020-08-14       Impact factor: 14.136

4.  Cocaine Exposure Increases Blood Pressure and Aortic Stiffness via the miR-30c-5p-Malic Enzyme 1-Reactive Oxygen Species Pathway.

Authors:  Wei Zhu; Huilan Wang; Jianqin Wei; Gregory C Sartor; Michelle Meiqi Bao; Clay T Pierce; Claes R Wahlestedt; Derek M Dykxhoorn; Chunming Dong
Journal:  Hypertension       Date:  2018-02-26       Impact factor: 10.190

5.  Monotropein alleviates H2O2‑induced inflammation, oxidative stress and apoptosis via NF‑κB/AP‑1 signaling.

Authors:  Feng Jiang; Xiao-Rong Xu; Wei-Ming Li; Kun Xia; Le-Feng Wang; Xin-Chun Yang
Journal:  Mol Med Rep       Date:  2020-09-29       Impact factor: 2.952

6.  Bacteria-Elicited Specific Thrombosis Utilizing Acid-Induced Cytolysin A Expression to Enable Potent Tumor Therapy.

Authors:  Wenjun Qin; Wenxuan Xu; Longyu Wang; Debao Ren; Yibin Cheng; Wen Song; Tao Jiang; Lixin Ma; Cheng Zhang
Journal:  Adv Sci (Weinh)       Date:  2022-04-11       Impact factor: 17.521

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.